Sandra L. Jimmo - Concepedia

Author

Sandra L. Jimmo

Queen's University

Also Known As

S Jimmo, S L Jimmo, S. Jimmo, Sandra Jimmo, Sandra L Jimmo, Sandra L. Jimmo

Publications

826

Citations

H-Index

Concepts

All Affiliations

Queen's University

About

Sandra L. Jimmo is an author at Queen's University specializing in medicine, cell signaling, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	259
2	Biochemistry	3	3	170
3	Health Sciences	2	2	109
4	Natural Sciences	2	2	140
5	Social Sciences	1	1	10

Sandra L. Jimmo

Publications

496

Citations

H-Index

Page 1

	Year	Citations
Distribution of amiodarone and its metabolite, desethylamiodarone, in human tissues James F. Brien, Sandra L. Jimmo, F. James Brennan, Canadian Journal of Physiology and Pharmacology	1987	106
Expression of Phosphodiesterase 4D (PDE4D) Is Regulated by Both the Cyclic AMP-dependent Protein Kinase and Mitogen-activated Protein Kinase Signaling Pathways Hanguan Liu, Daniel Palmer, Sandra L. Jimmo, Journal of Biological Chemistry Molecular BiologyPhosphodiesterase 4DCellular PhysiologySignaling PathwayReceptor Tyrosine Kinase	2000	86
Zinc alters conformation and inhibits biological activities of nerve growth factor and related neurotrophins Gregory M. Ross, Igor L. Shamovsky, Gail Lawrance, Nature Medicine Related NeurotrophinsNeuroanatomyBioactive MetalPhysiologyNerve Growth Factor	1997	79
Protein Kinase A Phosphorylation of Human Phosphodiesterase 3B Promotes 14-3-3 Protein Binding and Inhibits Phosphatase-catalyzed Inactivation Daniel Palmer, Sandra L. Jimmo, Daniel R. Raymond, Journal of Biological Chemistry Molecular Biology14-3-3 ProteinsSignaling PathwayReceptor Tyrosine KinaseAutophagy	2007	54
Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate. Gerald S. Marks, Brian E. McLaughlin, Sandra L. Jimmo, Drug Metabolism and Disposition	1995	49
Reduced Phosphodiesterase 3 Activity and Phosphodiesterase 3A Level in Synthetic Vascular Smooth Muscle Cells: Implications for Use of Phosphodiesterase 3 Inhibitors in Cardiovascular Tissues Heather A. Dunkerley, Douglas G. Tilley, Daniel Palmer, Molecular Pharmacology	2002	36
Rapid high-performance liquid chromatographic analysis of amiodarone and <i>N</i>-desethyl-amiodarone in serum James F. Brien, Sandra L. Jimmo, Paul W. Armstrong Canadian Journal of Physiology and Pharmacology	1983	30
Altered Phosphodiesterase 3-Mediated cAMP Hydrolysis Contributes to a Hypermotile Phenotype in Obese JCR:LA-cp Rat Aortic Vascular Smooth Muscle Cells Stuart J. Netherton, Sandra L. Jimmo, Daniel Palmer, Diabetes Pde3 ActivityObese JcrCellular PhysiologyInsulin SignalingMetabolic Syndrome	2002	30
Disposition of amiodarone and its proximate metabolite, desethylamiodarone, in the dog for oral administration of single-dose and short-term drug regimens. James F. Brien, Sandra L. Jimmo, F. James Brennan, Drug Metabolism and Disposition	1990	16
Release of glutamate and gamma-aminobutyric acid in the ovine fetal hippocampus: ontogeny and effect of hypoxia. Donald H. Penning, J Patrick, Sandra L. Jimmo, PubMed Brain DevelopmentGamma-aminobutyric AcidNeurotransmitterNeurotransmissionPotassium Ion	1991	10

Page 1